Criteo S.A. (CRTO) Guidance & Earnings Results
On 2026-08-05 Criteo S.A. lowered guidance: "Updated outlook reflects a more conservative view of business…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CRTOCriteo S.A.Follow CRTO — free
—
Price chart with a free account
- Market cap
- 729.1M
- P/E TTM
- 7.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 5 Aug 26 | Lowered | Updated outlook reflects a more conservative view of business trends · full year |
| 6 May 26 | Lowered | FY26 Contribution ex-TAC: low-single-digit decline (prior: not explicitly stated but implied growth); Q2 Contribution ex-TAC $260-264M (-11% to -9% cc); Q2 Adj EBITDA $67-71M · full year |
| 11 Feb 26 | Mixed | FY26 Contribution ex-TAC growth flat to +2% constant currency; Adj EBITDA margin 32-34%; Q1 2026 Contribution ex-TAC $245-250M (-11% to -9% YoY CC); Q1 Adj EBITDA $50-55M · full year |
| 29 Oct 25 | Raised | FY2025: Contribution ex-TAC growth +3% to +4% constant currency (unchanged); Adjusted EBITDA margin ~34% of Contribution ex-TAC (raised from 33% to 34%). Q4 2025: Contribution ex-TAC $325M-$331M; Adjusted EBITDA $113M-$119M. · full year |
| 30 Jul 25 | Raised | FY25 Contribution ex-TAC growth raised to +3-4% at constant currency from low-single-digit; Q3 2025 Contribution ex-TAC $277-283M (+5-7% YoY cc); Q3 2025 Adjusted EBITDA $81-87M; FY25 Adjusted EBITDA margin ~33-34% of Contribution ex-TAC · full year |
Criteo S.A. — questions
- What guidance did Criteo S.A. give?
- On 2026-08-05: "Updated outlook reflects a more conservative view of business trends"
- When does Criteo S.A. report earnings?
- Criteo S.A.'s next earnings report is expected on 2026-10-27.
Every figure on this page comes from Criteo S.A.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.